Ahmedabad based contract research and manufacturing player Dishman Pharmaceuticals & Chemicals posted a 61.63 per cent drop in net profit for the quarter ended December 31, 2012 to Rs 5.74 crore from Rs 14.96 crore in the corresponding quarter last fiscal. The income from operations during the quarter grew by 3.15 per cent to Rs 103.29 crore.
As for the consolidated results, the net profit for the quarter under review dipped by 1.85 per cent to Rs 16.41 crore, while the income from operations increased from Rs 266.19 crore in the third quarter of last fiscal to Rs 325.29 crore in the third quarter of FY13, up 22.2 per cent.
|Chennai||Rs. 24500.00 (-0.33%)|
|Mumbai||Rs. 25480.00 (-0.08%)|
|Delhi||Rs. 25200.00 (0%)|
|Kolkata||Rs. 25000.00 (0%)|
|Kerala||Rs. 24400.00 (-0.41%)|
|Bangalore||Rs. 24450.00 (0%)|
|Hyderabad||Rs. 24580.00 (0%)|